ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Sanofi licences ImmuNext autoimmune disease drug
pharmatimes
January 17, 2017Sanofi and ImmuNext have announced an agreement focused on the development of a novel antibody with the potential to treat a range of autoimmune diseases including lupus and multiple sclerosis.
Pharma Sources Insight July 2025
